AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab (December 21, 2004). doi:10.1152/ajpendo.00333.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/5/E980    most recent
00333.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reiter, A. K.
Right arrow Articles by Jefferson, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reiter, A. K.
Right arrow Articles by Jefferson, L. S.
Submitted on July 26, 2004
Accepted on December 20, 2004

Repression of Protein Synthesis and mTOR Signaling in Rat Liver Mediated by the AMP-Activated Protein Kinase Activator Aminoimidazole Carboxamide Ribonucleoside

Ali K. Reiter1, Douglas R. Bolster1, Stephen J. Crozier1, Scot R. Kimball1, and Leonard S. Jefferson1*

1 Department of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, Hershey, PA, USA

* To whom correspondence should be addressed. E-mail: jjefferson{at}psu.edu.

The studies described herein were designed to investigate the effects of 5- aminoimidazole-4-carboxamide 1-{beta}-D-ribonucleoside (AICAR), an activator of the AMP-activated protein kinase (AMPK), on the translational control of protein synthesis and signaling through the mammalian target of rapamycin (mTOR) in rat liver. Effects of AICAR observed in vivo were compared to those obtained in an in situ perfused liver preparation in order to investigate activation of AMPK in the absence of accompanying changes in hormones and nutrients. AMPK became hyperphosphorylated, as assessed by a gel-shift analysis, in response to AICAR both in vivo and in situ; however, increased relative phosphorylation at the Thr172 site on the kinase was observed only in perfused liver. Phosphorylation of AMPK either in vivo or in situ was associated with a repression of protein synthesis as well as decreased phosphorylation of a number of targets of mTOR signaling including ribosomal protein S6 kinase (S6K)1, eukaryotic initiation factor (eIF)4G, and eIF4E-binding protein (4E-BP)1. The phosphorylation changes in eIF4G and 4E-BP1 were accompanied by a reduction in the amount of eIF4E present in the active eIF4E.eIF4G complex and an increase in the amount present in the inactive eIF4E.4E-BP1 complex. Reduced insulin signaling as well as differences in nutrient availability may have contributed to the effects observed in vivo since AICAR caused a fall in the serum insulin concentration. Overall, however, the results from both experimental models support a scenario in which AICAR directly represses protein synthesis and mTOR signaling in the liver through an AMPK-dependent mechanism.




This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
G. R. Steinberg and B. E. Kemp
AMPK in Health and Disease
Physiol Rev, July 1, 2009; 89(3): 1025 - 1078.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. L. Yuan, N. Sharma, D. A. Gilge, W. C. Stanley, Y. Li, M. Hatzoglou, and S. F. Previs
Preserved protein synthesis in the heart in response to acute fasting and chronic food restriction despite reductions in liver and skeletal muscle
Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E216 - E222.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
D. M. Thomson, C. A. Fick, and S. E. Gordon
AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions
J Appl Physiol, March 1, 2008; 104(3): 625 - 632.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. E. Gleason, D. Lu, L. A. Witters, C. B. Newgard, and M. J. Birnbaum
The Role of AMPK and mTOR in Nutrient Sensing in Pancreatic beta-Cells
J. Biol. Chem., April 6, 2007; 282(14): 10341 - 10351.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
M.-J. Lee, D. Feliers, M. M. Mariappan, K. Sataranatarajan, L. Mahimainathan, N. Musi, M. Foretz, B. Viollet, J. M. Weinberg, G. G. Choudhury, et al.
A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F617 - F627.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
D. L. Williamson, D. R. Bolster, S. R. Kimball, and L. S. Jefferson
Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR.
Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E80 - E89.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
B. Viollet, M. Foretz, B. Guigas, S. Horman, R. Dentin, L. Bertrand, L. Hue, and F. Andreelli
Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders
J. Physiol., July 1, 2006; 574(1): 41 - 53.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
B. Xue and B. B. Kahn
AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues
J. Physiol., July 1, 2006; 574(1): 73 - 83.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
E. B. Taylor, W. J. Ellingson, J. D. Lamb, D. G. Chesser, C. L. Compton, and W. W. Winder
Evidence against regulation of AMP-activated protein kinase and LKB1/STRAD/MO25 activity by creatine phosphate
Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E661 - E669.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Funai, J. D. Parkington, S. Carambula, and R. A. Fielding
Age-associated decrease in contraction-induced activation of downstream targets of Akt/mTor signaling in skeletal muscle
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R1080 - R1086.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.